<html class="no-js" lang="en">
    <head>
    <meta charset="utf-8">
  
    <meta http-equiv="x-ua-compatible" content="ie=edge">
    <title>Rising Retina Clinic</title>
    <meta name="robots" content="noindex, follow">
    <meta name="description" content="">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <!-- Favicon -->
    <link rel="shortcut icon" type="image/x-icon" href="images/cropped-fevicon.png">
    <!-- CSS
       ============================================ -->
    <!-- Bootstrap CSS -->
    <link rel="stylesheet" href="css/bootstrap.min.css">
    <!-- Fontawesome -->
    <!-- <link rel="stylesheet" href="css/fontawesome.css"> -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.css" integrity="sha512-5A8nwdMOWrSz20fDsjczgUidUBR8liPYU+WymTZP1lmY9G6Oc7HlZv156XqnsgNUzTyMefFTcsFH/tnJE/+xBg==" crossorigin="anonymous" referrerpolicy="no-referrer" />
    <!-- Flaticon -->
    <link rel="stylesheet" href="css/flaticon.css">

    <!-- optico Icons -->
    <link rel="stylesheet" href="css/pbminfotech-base-icons.css">
    <!-- Themify Icons -->
    <link rel="stylesheet" href="css/themify-icons.css">
    <!-- Slick -->
    <link rel="stylesheet" href="css/swiper.min.css">
    <!-- Magnific -->
    <link rel="stylesheet" href="css/magnific-popup.css">
    <!-- AOS -->
    <link rel="stylesheet" href="css/aos.css">
    <!-- Shortcode CSS -->
    <link rel="stylesheet" href="css/shortcode.css">
    <!-- Base CSS -->
    <link rel="stylesheet" href="css/base.css">
    <!-- Style CSS -->
    <link rel="stylesheet" href="css/style.css">
    <!-- Responsive CSS -->
    <link rel="stylesheet" href="css/responsive.css">
    <!-- REVOLUTION STYLE SHEETS -->
    <link rel="stylesheet" type="text/css" href="revolution/rs6.css">

 </head>
 <style>
   .tab {
   /* Your tab styles here */
}

.tab.active {
   /* Your active tab styles here */
}

.tab-content {
   display: none;
   /* Your tab content styles here */
}

.tab-content.active {
   display: block;
   /* Your active tab content styles here */
}
 </style>

 <body data-aos-easing="ease" data-aos-duration="400" data-aos-delay="0">
    <!-- page wrapper -->
    <div class="page-wrapper">

       <!-- Header Main Area -->
       <header class="site-header header-style-1">
          <div class="site-header-menu">
             <div class="container-fuild">
                <div class="d-flex align-items-center justify-content-between">
                   <div class="site-branding">
                      <!-- Logo area -->
                      <h1 class="site-title">
                         <a href="index.html" rel="home">
                            <img class="logo-img" src="images/logo.jpg" alt="Cardioly Demo1" title="Cardioly Demo1">
                         </a>
                      </h1>				        
                   </div>
                   <div class="flex-grow-1">
                      <div class="pre-header">
                         <div class="container-fuild">
                            <div class="d-md-flex justify-content-between">
                               <div class="pbmit-pre-header-left">
                               <span class="pbmit-label"> <a href="index.html">Home</a> 
                            
                                  </span>
                                <span class="pbmit-label"><a href="inquiry.html">Inquiry</a></span>
                             <span class="pbmit-label"><a href="contact.html">Contact Us</a></span>
                               </div>
                               <div class="pbmit-pre-header-right">
                                  <ul class="pbmit-contact-info d-flex align-items-center">
                                     <li>
                                        <i class="fa fa-envelope" aria-hidden="true"></i> Email  : risingretina@yahoo.com
                                     </li>
                                     <li>
                                        <i class="fa fa-phone" aria-hidden="true"></i> Phone : +91 79 2692 5232
                                     </li>
                                     <li>
                                        <ul class="pbmit-social-links d-flex align-items-center">
                                           <li class="pbmit-social-li pbmit-social-facebook">
                                              <a href="https://www.facebook.com/profile.php?id=100067116072489" target="_blank">
                                                <i class="fa fa-facebook-f"></i>
                                              </a>
                                           </li>
                                           <li class="pbmit-social-li pbmit-social-twitter">
                                              <a href="https://twitter.com/RisingRetina" target="_blank">
                                                <i class="fa fa-twitter"></i>
                                              </a>
                                           </li>
                                           <!-- <li class="pbmit-social-li pbmit-social-linkedin">
                                              <a href="#" target="_blank">
                                                 <i class="pbmit-base-icon-linkedin-squared"></i>
                                              </a>
                                           </li>
                                           <li class="pbmit-social-li pbmit-social-youtube">
                                              <a href="#" target="_blank">
                                                 <i class="pbmit-base-icon-youtube-play"></i>
                                              </a>
                                           </li> -->
                                        </ul>
                                     </li>
                                  </ul>						
                               </div>
                            </div>
                         </div>
                      </div>
                      <div class="site-header-menu-inner">
                         <div class="container-fuild">
                            <div class="row">
                               <div class="col-md-12">
                                  <div class="d-flex justify-content-between">
                                     <div class="site-navigation ml-auto">
                                        <nav class="main-menu navbar-expand-xl navbar-light">
                                           <div class="navbar-header">
                                              <!-- Toggle Button --> 
                                              <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
                                                 <!-- <i class="pbmit-base-icon-menu-1"></i> -->
                                                 <i class="fa fa-bars"></i>
                                              </button>
                                           </div>
                                           <div class="collapse navbar-collapse clearfix" id="navbarSupportedContent">
                                              <ul class="navigation clearfix">
                                                 <li class="dropdown ">
                                                    <a href="overview.html">Overview</a>
                                   
                                                </li>
                                                 <li class="dropdown">
                                                    <a href="technology.html">Technology</a>
          
                                          </li>
                                                 
                                                 <!-- <li class="dropdown">
                                                    <a href="#">Service</a>
                        
                                                 <span class="righticon"><i class="fa fa-angle-down"></i></span></li> -->
                                                 
                                                 <li class="dropdown">
                                                    <a href="infrastructure.html">Infrastructure</a>

                                                </li>
                                                <li class="dropdown">
                                                    <a href="patient.html">Patient Information</a>

                                               </li>
                                               <li>
                                                <a href="patient-services.html">Patient Services</a>

                                                </li>
                                                <li><a href="patient-education.html">Patient Education</a>
                                                </li>
                                              </ul>
                                           </div>
                                        </nav>
                                     </div>
                                     <div class="pbmit-right-box">
                                        <div class="pbmit-header-search-btn">
                                           <a href="#"><i class="fa fa-search" aria-hidden="true"></i></a>
                                        </div>
                                        <div class="menu-right-box d-flex align-items-center">
                                           <div class="pbmit-header-button">
                                              <a href="contact-us.html" class="pbmit-btn">Appointment</a>
                                           </div>
                                        </div>
                                     </div>
                                  </div>
                               </div>
                            </div>
                         </div>
                      </div>
                   </div>
                </div>
             </div>
          </div>
         

        
          </div>
       </header>

       <div class="pbmit-title-bar-wrapper">
        <div class="container">
           <div class="pbmit-title-bar-content">
              <div class="pbmit-title-bar-content-inner">
                 <div class="pbmit-tbar">
                    <div class="pbmit-tbar-inner container">
                       <h1 class="pbmit-tbar-title"> Get Pumbed Up <br/> about Vision</h1>
                    </div>
                 </div>
                 <div class="pbmit-breadcrumb">
                    <div class="pbmit-breadcrumb-inner">
                       <span><a title="" href="#" class="home"><span>Rising Retina Clinic</span></a></span>
                       <span class="sep"><i class="fa fa-angle-right" aria-hidden="true"></i></span>
                       <span><span class="post-root post post-post current-item">Patient Information</span></span>
                    </div>
                 </div>
              </div>
           </div>
        </div>
     </div>


       <!-- Header Main Area End Here -->

       <!-- Page Content -->
       <div class="page-content">

 

         <!-- <section>
            <div class="container">
               <div class="row">
                  <div class="col-lg-3 service-left-col order-2 order-lg-1">
                     <aside class="service-sidebar">
                        <aside class="widget post-list">
                           <div class="all-post-list">
                              <ul>
                                 <li class="post-active"><a href="patient-education.html"> Diabetic Retinopathy (DR)</a></li>
                                 <li ><a href="retinal.html">  Retinal Detachment </a></li>
                                 <li ><a href="age.html"> Age Related Macular Degeneration (AMD) </a></li>
                                 <li ><a href="brvo.html">Branch Retinal Vein Occlusion (BRVO)</a></li>
                                 <li ><a href="crvo.html">Central Retinal Vein Occlusion (CRVO)</a></li>
                                 <li ><a href="crao.html">Central Retinal Artery Occlusion (CRAO)</a></li>
                                 <li ><a href="csr.html">Central Serous Retinopathy (CSR)</a></li>
                                 <li ><a href="macular_edema.html">Macular Edema</a></li>
                                 <li ><a href="macular_hole.html">Macular Hole</a></li>
                                 <li ><a href="macular_pucker.html">Macular Pucker</a></li>
                                 <li ><a href="rp.html">Retinitis Pigmentosa (RP)</a></li>
                                 <li ><a href="toxoplasmosis.html">Toxoplasmosis</a></li>
                                 <li ><a href="lattice.html">Lattice Degeneration</a></li>
                                 <li ><a href="floater.html">Floaters & Flashes</a></li>
                
                              </ul>
                           </div>
                        </aside>


                     </aside>
                  </div>
                  <div class="col-lg-9 service-right-col order-1">

                     <div class="about-left-section">
 
 
                 
                  </div>
               </div>
            </div>
         </section> -->


         <section>
            <div class="container">
               <div class="row">
                  <div class="col-lg-3 service-left-col ">
                     <aside class="service-sidebar">
                        <aside class="widget post-list">
                           <div class="all-post-list">
                              <div id="tab-container">
                                 <ul>

                                    <li class="tab post-active"><a href=""> Diabetic Retinopathy (DR)</a></li>
                                    <li class="tab"><a href=""> Retinal Detachment </a></li>
                                    <li class="tab"><a href=""> Age Related Macular Degeneration (AMD) </a></li>
                                    <li class="tab"><a href="">Branch Retinal Vein Occlusion (BRVO)</a></li>
                                    <li class="tab"><a href="">Central Retinal Vein Occlusion (CRVO)</a></li>
                                    <li class="tab"><a href="">Central Retinal Artery Occlusion (CRAO)</a></li>
                                    <li class="tab"><a href="">Central Serous Retinopathy (CSR)</a></li>
                                    <li class="tab"><a href="">Macular Edema</a></li>
                                    <li class="tab"><a href="">Macular Hole</a></li>
                                    <li class="tab"><a href="">Macular Pucker</a></li>
                                    <li class="tab"><a href="">Retinitis Pigmentosa (RP)</a></li>
                                    <li class="tab"><a href="">Toxoplasmosis</a></li>
                                    <li class="tab"><a href="">Lattice Degeneration</a></li>
                                    <li class="tab"><a href="">Floaters & Flashes</a></li>


                                 </ul>
                              </div>
                           </div>
                        </aside>
                     </aside>
                  </div>
                  <div class="col-lg-9 service-right-col order-1">
                     <div class="about-left-section">
                        <div class="tab-content active">
                           <div class="about-left-section">
                              <div class="pbmit-short-description">
                                 <h2>Diabetic Retinopathy</h2>
                              </div>           
                              <div class="pbmit-short-description">
       
                                  <ul style="list-style: disc;padding-left:20px;">
                                     <li>What is diabetes !! - Diabetes mellitus is the inability of the body to use and store sugar properly, resulting in high blood glucose (sugar) levels</li>
                                     <li>Diabetes results in damage to veins, arteries and capillaries throughout the body.</li>
                                     <li>Diabetes affecting vision –
                                       <br/>
                                       <ul style="list-style: circle;padding-left:20px;">
                                           <li>Increases the likelihood of cataracts</li>
                                           <li>Increases the risk glaucoma</li>
                                           <li>Risk of developing diabetic retinopathy: damage occurs to the fragile blood vessels of the retina</li>     
                                        </ul>
       
                                     </li>
                                     <li>Diabetic retinopathy is a leading cause of new cases of blindness in people aged 20 to 74 years</li>
                                  </ul>
                              </div>
                              <div class="pbmit-short-description">
                                <h3>Etiology:</h3>
                                  <ul style="list-style: number;padding-left:20px;">
                                     <li>The duration of diabetes:
                                       <br/>
                                       <ul style="list-style: circle;padding-left:20px;">
                                           <li>It is the most important factor.</li>
                                           <li>In patients diagnosed as having diabetes before the age of 30 years, the incidence of DR :<br/>
                                               <ul style="list-style: disc;padding-left:20px;">
                                                   <li>After 10 years is 50%</li>
                                                   <li>After 30 years is  90%</li>
                                                </ul>
                                           </li>
                                        </ul>
                                     </li>
                                     <li>Glycemic control:<br/>
                                       <ul style="list-style: circle;padding-left:20px;">
                                       <li>Increased severity of diabetic retinopathy is associated with poorer glucose control</li>
                                       </ul>
                                     </li>
                                     <li>Miscellaneous factors:<br/>
                                       <ul style="list-style: circle;padding-left:20px;">
                                           <li>Pregnancy</li>
                                           <li>Systemic Hypertension</li>
                                           <li>Renal Disease</li>
                                           <li>Anaemia.(↓Oxygen )</li>
                                           <li>Elevated Serum lipid.</li>
                                           <li>Aarotid artery occlusive disease</li>
                                           <li>Alcohol</li>
                                           <li>Obesity</li>
       
                                           </ul>
                                     </li>
                                     <li>PVD:</li>
                                     <li>High myopia</li>
                                     <li>Removal of cataract</li>
                                  </ul>
                              </div>
       
       
                           <div class="pbmit-short-description">
                               <h2>Ophthalmic Features</h2>
                            </div>
       
                            <div class="pbmit-short-description">
                           
                                 <ul style="list-style: number;padding-left:20px;">
                                    <li><h4>Microaneurysms</h4>
                                      <ul style="list-style: circle;padding-left:20px;">
                                          <li>Located in the inner nuclear layer.</li>
                                          <li>The first clinically detectable lesions.</li>
                                          <li>Small round dots .(20-200 μ)</li>
                                          <li>Mostly located near and temporal to the macula.</li>
                                          <li>When coated with blood they may be indistinguishable from dot haemorrhages.</li>
                                       </ul>
                                    </li>
                                    <li>
                                       <h4>Haemorrhages:</h4> The clinical appearance depending on location<br/>
                                      <ul style="list-style: circle;padding-left:20px;">
                                      <li>'Dot' and 'Blot':<br/>
                                       <ul style="list-style: disc;padding-left:20px;">
                                          <li>Originating from the venous end of the capillaries.    *located in the compact middle layers of the retina.</li>
                                       </ul>
                                      </li>

                                      <li>Flame-shaped:<br/>
                                       <ul style="list-style: disc;padding-left:20px;">
                                          <li>Originate from the more superficial precapillary   arterioles, follow the course of the retinal nerve fibre layer. (liner disribution)</li>
                                       </ul>
                                      </li>
                                      </ul>
                                    </li>
                                    <li><h4>Hard exudates :</h4>
                                      <ul style="list-style: circle;padding-left:20px;">
                                          <li>located between the inner plexiform and inner nuclear layers of the retina. (OPL)</li>
                                          <li>They are often distributed in a (circinate pattern).</li>       
                                          </ul>
                                    </li>
                                    <li><h4>Retinal edema :</h4>
                                       <ul style="list-style: circle;padding-left:20px;">
                                          <li>Located between the outer plexiform and inner nuclear layers.</li>
                                          <li>Later it may involve the inner plexiform and nerve fibre layers, until eventually the entire thickness of the retina may become oedematous.</li>       
                                          <li>With further accumulation of fluid, the fovea assumes a cystoid appearance .</li>
                                       </ul>
                                    </li>
                                    <li><h4>Cotton-wool spots: (Soft exudates )</h4>
                                       <ul style="list-style: circle;padding-left:20px;">
                                          <li>Nerve fiber layer infarction.</li>
                                          <li>Caused by capillary occlusion in the retinal nerve fibre layer.</li>       
                                       </ul>
                                    </li>
                                    <li><h4>Intraretinal microvascular abnormalities (lRMA) :</h4>
                                       <ul style="list-style: circle;padding-left:20px;">
                                          <li>Dilated, tortous retinal capillaries that act as a shunt between arterioles and venules.</li>
                                          <li>Frequently seen adjacent to areas of capillary closure.</li>       
                                       </ul>
                                    </li>
                                    <li><h4> New Vessels:</h4>
                                       <ul style="list-style: circle;padding-left:20px;">
                                          <li>Unlike IRMA, they arise on the retinal surface and may extend or be pulled into the vitreous cavity.</li>
                                          <li>NVD : NV appears on or within one DD of disc margin .</li>   
                                          <li>NVE : any other location</li>    
                                       </ul>
                                    </li>
                                    <li><h4>Fibrous Glial proliferation :</h4>
                                       <ul style="list-style: circle;padding-left:20px;">
                                          <li>Accompained growth of new vessels.</li>
                                          <li>It is proliferation between the posterior vitreous gel and the ILM.</li>   
                                          <li>Derived from retinal glial cells and fibrocytes</li>    
                                       </ul>
                                    </li>
                                 </ul>
                             </div>

                             <div class="pbmit-short-description">
                                 <div class="row">
                                    <div class="col-sm-6">
                                       <img src="images/retinal_detachment_clip_image002.jpg" class="img-fluid" alt="retina">
                                    </div>
                                    <div class="col-sm-6">
                                       <img src="images/hard_excudate.jpg" class="img-fluid" alt="retina">
                                    </div>
                                    <div class="col-sm-6">
                                       <img src="images/diabetic_retinopathy.jpg" class="img-fluid" alt="retina">
                                    </div>
                                 </div>
                           </div>
                       
                        </div>
                        </div>

                        <div class="tab-content">

                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
        <tbody><tr>
		  <td  align="left" valign="top">&nbsp;</td>
		  <td  align="left" valign="top" class="Page_title"><h2>Retinal Detachment</h2></td>
		  <td  align="left" valign="top">&nbsp;</td>
		</tr>
        <tr>
		  <td  align="left" valign="top">&nbsp;</td>
		  <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
		  <p>Retinal Detachment (R.D.)  is a separation of the sensory retina from the  retinal pigment epithelium(R.P.E) by sub retinal fluid(S.R.F)</p>
		    <p>There are two main types.</p>
		    <ol>
			  <li><span dir="ltr">Rhegmatogenous or Primary R.D.</span></li>
		      <li><span dir="ltr">Nonrhegmatous or Secondary R.D.</span></li>
			</ol>
		    <p>Secondary R.D sub divided in to two types:</p>
		    <ul style="list-style: disc;padding-left: 20px;">
		      <li><span dir="ltr">Tractional R.D.</span></li>
		      <li><span dir="ltr">&nbsp;Exudative(Serous) R.D</span></li>
	        </ul>
		    <p><strong><u><h4>Rhegmatogenous RD</h4></u></strong></p>
		    <ul style="list-style: disc;padding-left: 20px;">
		      <li><span dir="ltr">Rhegmatogenous R.D is a condition in which fluid from vitreous cavity passes through a full thickness retinal  defect in to the sub retinal space to cause separation of the neural retina  from the underlying R.P.E</span></li>
		      <li><span dir="ltr">It affects about 1:10,000 of the  population each year</span></li>
	        </ul>
		    <p><img  height="151" src="images/retinal_detachment_clip_image002.jpg"></p>
		    <p><strong><u><h4>Etiology</h4></u></strong></p>
		    <ul  style="list-style: disc;padding-left: 20px;">
		      <li><span dir="ltr">Neural retinal break</span></li>
		      <li><span dir="ltr">Vitreous liquefaction and detachment </span></li>
		      <li><span dir="ltr">Vitreoretinal traction</span></li>
		      <li><span dir="ltr">Intra ocular fluid currents  associated with&nbsp;&nbsp; movement of liquid  vitreous and sub retinal&nbsp; fluid</span></li>
		      <li><span dir="ltr">History of trauma</span></li>
		      <li><span dir="ltr">History of previous ocular disease</span></li>
		      <li><span dir="ltr">History of systemic diseases </span></li>
	        </ul>
		    <p><strong><u><h4>Ophthalmic Features</h4></u></strong></p>
		    <ul style="list-style: disc;padding-left: 20px;">
		      <li><span dir="ltr">Age: Common age group is 40-70  years</span></li>
		      <li><span dir="ltr">Sex: 60 % case comprises by males</span></li>
		      <li><span dir="ltr">Hereditary: although a no.of  pedigree shows familial detachments, most cases are sporadi</span></li>
		      <li><span dir="ltr">Common complains -</span></li>
		      <li><span dir="ltr">Flashes of lights(Photopsia)</span></li>
		      <li><span dir="ltr">Floaters- may be </span></li>
		      <li><span dir="ltr">Solitary ring shaped  opacity(Weiss Ring) </span></li>
		      <li><span dir="ltr">Cobwebs </span></li>
		      <li><span dir="ltr">Sudden shower of minute red  colored or dark spots</span></li>
		      <li><span dir="ltr">Localized relative loss in field  of vision</span></li>
		      <li><span dir="ltr">sudden painless loss of vision </span></li>
		      <li><span dir="ltr">Blurring of distant vision</span></li>
		      <li><span dir="ltr">Pupil – RAPD</span></li>
		      <li><span dir="ltr">Fundus Examination – Loss of  normal fundal glow</span></li>
		      <li><span dir="ltr">Retinal breaks:</span></li>
		      <li><span dir="ltr">Present in about 70% of </span></li>
		      <li><span dir="ltr">The eyes with tobacco dust.</span></li>
		      <li><span dir="ltr">appears as red discontinuities in  the retinal surface</span></li>
		      <li><span dir="ltr">Upper temporal quadrant is the  commonest site for retinal break </span></li>
	        </ul>
		    <p><img  height="188" src="images/retinal_detachment_clip_image004.jpg" alt="C:\My Documents\rd.Rt.jpg"> <img  height="188" src="images/retinal_detachment_clip_image006.jpg" alt="C:\WINDOWS\Desktop\TEAR.jpg"></p>
		    
		    <p><img  height="342" src="images/retinal_detachment_clip_image008.jpg" alt="C:\My Documents\rd.Rt001.jpg"><br>
                <strong>Shape of R.D in relation to primary break</strong></p>
		    
		    <p>Retinal signs depends on  duration of R.D.</p>
		    <ol>
		      <li><span dir="ltr">Fresh R.D</span></li>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">Detached retina has a convex  configuration,slightly opaque and corrugated appearance, undulates freely with  eye movements</span></li>
				</ul>
		      <li><span dir="ltr">Long standing retinal detachment</span></li>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">Retinal thinning secondary to atrophy,  secondary intraretinal cysts if more than 1 year,&nbsp; sub retinal&nbsp;  demarcation lines, present after 3 months.</span></li>
				</ul>
	        </ol>
		    <p><strong><h4><u>Treatment</u></h4></strong></p>
		    <ol>
		      <li><span dir="ltr">Cryotherapy</span></li>
		      <li><span dir="ltr">Scleral Buckling</span></li>
		      <li><span dir="ltr">Pneumatic Retinopexy</span></li>
		      <li><span dir="ltr">Vitrectomy</span></li>
		    </ol>
		    <ol>
		      <li><span dir="ltr"><strong>Cryo therapy</strong></span></li>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">Cryotherapy (freezing) or laser photocoagulation&nbsp; are occasionally used alone to wall off a  small area of retinal detachment so that the detachment does not spread.</span></li>
				</ul>
		      <li><span dir="ltr"><strong>Scleral Buckle surgery</strong></span></li>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">Scleral buckle surgery is an established treatment in which the eye surgeon sews one or  more silicone bands (bands, tyres) to the sclera (the white outer coat of the  eyeball). The bands push the wall of the eye inward against the retinal hole,  closing the break or reducing fluid flow through it and reducing the effect of  vitreous traction thereby allowing the retina to re-attach. Cryotherapy  (freezing) is applied around retinal breaks prior to placing the buckle. Often  subretinal fluid is drained as part of the buckling procedure. The buckle  remains in situ. The most common side effect of a scleral operation is myopic  shift.</span></li>
				</ul>
		      <li><span dir="ltr"><strong>Pneumatic retinopexy</strong></span></li>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">This operation is  generally performed in the doctor's office under local anesthesia. It is  another method of repairing a retinal detachment in which a gas bubble (SF6 or  C3F8 gas) is injected into the eye after which laser or freezing treatment is  applied to the retinal hole. The patient's head is then positioned so that the  bubble rests against the retinal hole. Patients may have to keep their heads  tilted for several days to keep the gas bubble in contact with the retinal  hole. The surface tension of the air/water interface seals the hole in the  retina, and allows the retinal pigment epithelium to pump the subretinal space  dry and suck the retina back into place. This strict positioning requirement  makes the treatment of the retinal holes and detachments that occurs in the  lower part of the eyeball impractical. This procedure is usually combined with  cryopexy or laser photocoagulation.</span></li>
				</ul>
	          <li><span dir="ltr"><strong>Vitrectomy</strong>
		    	<ul style="list-style: circle;padding-left: 20px;">
				  <li><span dir="ltr">Vitrectomy is an increasingly used treatment for retinal detachment. It  involves the removal of the vitreous gel and is usually combined with filling  the eye with either a gas bubble (SF6 or C3F8 gas) or silicon oil. An advantage of using gas in this operation is that there  is no myopic shift after the operation and gas is absorbed within a few weeks.  Silicon oil (PDMS), if filled needs to be removed after a period of 2–8 months  depending on surgeon's preference. Silicon oil is more commonly used in cases  associated with proliferative vitreo-retinopathy (PVR). A disadvantage is that  a vitrectomy always leads to more rapid progression of a cataract in the  operated eye. In many places vitrectomy is the most commonly performed  operation for the treatment of retinal detachment.</span></li>
				</ul>
 	        </span></li></ol>
		  </td>
		  <td  align="left" valign="top">&nbsp;</td>
		</tr>
        <tr>
		  <td colspan="3" align="left" valign="top">&nbsp;</td>
		</tr>
        <tr>
		  <td colspan="3" align="center">&nbsp;</td>
		</tr>
	  </tbody></table>


                           </div>
                        </div>

                        <div class="tab-content">
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><h2>AMD</h2></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                 <ul style="list-style: disc;padding-left: 20px;">
                                   <li><span dir="ltr">A layer of the retina called the  retinal pigment epithelium (RPE) is disrupted by deposits called <em>drusen</em>,  or other age-related changes. These changes, if severe enough, may cause vision  to deteriorate. When the macula breaks down, you lose your central vision, but  it does not affect your peripheral (side) vision.</span></li>
                                   <li><span dir="ltr">A leading cause of severe vision  loss in people over 65 years of age ,associated with the aging process; the  macula may lose effectiveness over time.</span></li>
                                   </ul>
                                   <p><strong><u><h4>Ophthalmic Features</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Early AMD may be hardly  noticeable, and may only occur in one eye.</span></li>
                                     <li><span dir="ltr">Words on a page may look blurred.</span></li>
                                     <li><span dir="ltr">It may be difficult to recognize people’s  faces.</span></li>
                                      <li> A dark or  empty area may appear in the center of vision.</li>
                                     <li><span dir="ltr">Straight lines may look distorted.</span></li>
                                     <li><span dir="ltr">With AMD, dark areas may appear in  your central vision</span></li>
                                   </ul>
                                   <p><strong><u><h4>Two types of AMD</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr"><strong>Atrophic (Dry) AMD </strong>- Caused  by aging and thinning of macular tissues when drusen are present.</span>
                                       <ul style="list-style: circle;padding-left: 20px;">
                                         <li><span dir="ltr">Vision loss is usually gradual.</span></li>
                                         <li><span dir="ltr">Most common form.</span></li>
                                        </ul>
                                     </li>
                                     
                                     <li><span dir="ltr"><strong>Exudative (Wet) AMD</strong> - Caused  when abnormal</span>
                                       <ul style="list-style: circle;padding-left: 20px;">
                                         <li><span dir="ltr">Blood vessels form underneath the  retina. These vessels leak&nbsp; blood/fluid  and blur central vision.</span></li>
                                         <li><span dir="ltr">Vision loss may be rapid and severe. </span></li>
                                        </ul>
                                     </li>
                                   </ul>
                                   <p><img  height="188" src="images/amd_clip_image002.jpg"><img width="204" height="188" src="images/amd_clip_image004.jpg"><img  height="188" src="images/amd_clip_image006.jpg"></p>
           
                                   <p><strong><u><h4>Investigations</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Many people do not realize they  have a problem until vision blurs.</span></li>
                                     <li><span dir="ltr">Your ophthalmologist can detect early AMD&nbsp; during an eye exam that includes:</span></li>
                                     <li><span dir="ltr"><strong>Ophthalmoscopic examination</strong></span>
                                       <ul style="list-style: circle;padding-left: 20px;">
                                         <li>Fluorescein angiography - Dye is  injected into your arm where it travels through the body to the blood vessels  in your eye.</li>
                                         <li><span dir="ltr">Special photographs are taken of  your eye; dye will highlight abnormal blood vessel growth under the retina</span></li>
                                        </ul>
                                     </li>
                                    </ul>
                                   <p><img  height="144" src="images/amd_clip_image008.jpg"></p>
                                   <p><strong><u><h4>Make most of your vision</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">If you have been diagnosed with  AMD, you must monitor your vision every day with an Amsler Grid.</span></li>
                                     <li><span dir="ltr">With AMD, Amsler Grid may contain  blurry or wavy lines.</span></li>
                                     <li><span dir="ltr">Preserve good vision with regular  eye exams</span></li>
                                    </ul>
                                   <p><img  height="170" src="images/amd_clip_image010.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="170" src="images/amd_clip_image012.jpg"><br>
                                         <span class="style3"><strong>Amsler  Grid, as seen through a normal eye&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  Amsler Grid, as might be seen through an eye with AMD</strong></span></p>
                                   <p><strong><u><h4>Treatment (Dry AMD)</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">There is no treatment for dry AMD.</span></li>
                                     <li><span dir="ltr">Nutritional supplements may help  slow progression and impact of AMD:</span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Vitamins C, E</span></li>
                                       <li><span dir="ltr">Beta carotene</span></li>
                                       <li><span dir="ltr">Zinc </span></li>
                                      </ul>
                                    </ul>
                                   <p>(Vitamin supplements are not cures for AMD, nor can they  restore vision already lost from AMD.)</p>
                                   <p><img  height="156" src="images/amd_clip_image014.jpg"></p>
                                   <p><strong><u><h4>Treatment (Wet AMD)</h4></u></strong></p>
                                     <ol>
                                       <li><span dir="ltr"><strong>Thermal Laser Therapy</strong> - Used when abnormal blood  vessel growth is not under center of macula. High-energy, focused light beam  treats tiny area of retina by “burning” it; destroys abnormal underlying blood vessels, preventing further leakage/bleeding/growth</span></li>
                                   <ul style="list-style: circle;padding-left: 20px;">
                                     <li><span dir="ltr">Following treatment, your vision  may be more blurred than before; will stabilize within a few weeks.</span></li>
                                     <li><span dir="ltr">Scar forms where treatment  occurred, creating a permanent blind spot that might be noticeable in your  field of vision.</span></li>
                                     <li><span dir="ltr">Likely that 50% of wet AMD  patients who have laser procedure will need re-treatment within 3 to 5 years..</span></li>
                                    </ul>
                                       <li><span dir="ltr"><strong>Photo Dynamic Therapy (PDT)</strong> - If abnormal blood  vessels grow under center of macula, PDT may be a treatment option. Uses a  combination of a light-activated (photo- sensitive) drug and a special  low-power (cool) laser.</span></li>
                                   <ul style="list-style: circle;padding-left: 20px;">
                                     <li><span dir="ltr">Photosensitive drug injected into  vein in arm, where it travels throughout the body; attaches to molecules found  in abnormal blood vessels. Laser light targeted directly on the abnormal  vessels, activating the drug; drug causes damage specifically to those unwanted  blood vessels. After PDT, abnormal blood vessels may re-open; multiple  treatments may be required.</span></li>
                                    </ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr"><strong>Anti-VEGF treatment</strong> - A certain chemical in  your&nbsp;&nbsp; body is critical in causing  abnormal blood vessels to grow&nbsp; under the  retina, and is called vascular endothelial growth factor, or VEGF. There are several  drugs (anti-VEGF) that can block the trouble-causing VEGF. Blocking VEGF  reduces the growth of abnormal blood vessels, slows their leakage, and helps to  slow vision loss.</span></li>
                                   <ul style="list-style: circle;padding-left: 20px;">
                                     <li><span dir="ltr">The anti-VEGF drug is injected  into your eye with a very fine needle.(Your ophthalmologist will clean your eye  to prevent infection and will administer an anesthetic eye drops to your eye to  prevent pain.) </span></li>
                                     <li><span dir="ltr">Patients receive multiple  anti-VEGF injections over the course of many months.</span></li>
                                     <li><span dir="ltr">In some cases, your  ophthalmologist may recommend combining anti-VEGF treatment with other  therapies (i.e. some patients also receive photodynamic laser therapy).</span></li>
                                    </ul>
                                  </ol>
                                   <p><strong><u><h4>What happens when AMD cannot be treated?</h4></u></strong></p>
                                   <ul>
                                     <li><span dir="ltr">People with wet or dry AMD who  cannot be treated will not become blind—they will still have peripheral (side)  vision. </span></li>
                                    </ul>
                                   <ul>
                                     <li><span dir="ltr">With special low-vision  rehabilitation, devices and services, people can often learn how to “see” again  with remaining vision.</span></li>
                                    </ul>
                                   <p><strong><u><h4>Vision Rehabilitation</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Learn new strategies to accomplish  daily activities, Skills/devices/techniques help people with advanced AMD  regain confidence and live independently despite loss of central vision. </span></li>
                                     <li><span dir="ltr">Low Vision Aids- Optical  low-vision devices use lenses to magnify objects:</span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Magnifying spectacles</span></li>
                                       <li><span dir="ltr">Hand magnifiers</span></li>
                                       <li><span dir="ltr">Stand magnifiers</span></li>
                                       <li><span dir="ltr">Video magnifiers</span></li>
                                       <li><span dir="ltr">Telescopes</span></li>
                                       <li><span dir="ltr">Large-print books, newspapers,  magazines, playing cards, checks</span></li>
                                       <li><span dir="ltr">Writing/signing guides</span></li>
                                       <li><span dir="ltr">High contrast/large number  telephones, thermostats, watches, remotes</span></li>
                                     <li><span dir="ltr">Talking books, watches, timers, medical devices</span></li>
                                      </ul>
                                    </ul>
                                  </td>
                             
                               </tr>


                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <div class="about-left-section">
                            
                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><h2>BRANCH RETINAL VEIN OCCLUSION (BRVO)</h2></td>
                             
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">The clinical picture of branch retinal vein occlusion is retinal  hemorrhages that are segmental in distribution. </span></li>
                                      <li><span dir="ltr">The apex of the obstructed tributary vein almost always lies at an  arteriovenous crossing. Usually some degree of pathologic arteriovenous nicking  is present.</span></li>
                                      <li><span dir="ltr">The occlusion is commonly located one or two disc diameters away from  the optic disc. However, the occlusion may lie at a point near the disc edge  or, less frequently, may involve one of the smaller, more peripheral tertiary  or macular branches. </span></li>
                                   </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="156" src="images/brvo_clip_image002.jpg"></p>
                                   <p><strong><u><h2>Etiology</h2></u></strong></p>
                                   <ul  style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Systemic Hypertension</span></li>
                                     <li><span dir="ltr">History of cardio vascular disease</span></li>
                                     <li><span dir="ltr">Increased cholesterol</span></li>
                                     <li><span dir="ltr">History of glaucoma</span></li>
                                     <li><span dir="ltr">High serum levels of a2 globulin</span></li>
                                    </ul>
                                   <p><strong><u><h2>Ophthalmic Features</h2></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">The clinical picture of branch retinal vein occlusion is <strong>retinal  hemorrhages</strong> that are segmental in distribution. </span></li>
                                     <li><span dir="ltr">The apex of the obstructed tributary vein almost always lies at an  arteriovenous crossing. Usually some degree of pathologic arteriovenous nicking  is present.</span></li>
                                     <li><span dir="ltr">The occlusion is commonly located one or two disc diameters away from  the optic disc. However, the occlusion may lie at a point near the disc edge  or, less frequently, may involve one of the smaller, more peripheral tertiary  or macular branches</span></li>
                                    </ul>
                                   <p><img  height="188" src="images/brvo_clip_image004.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="188" src="images/brvo_clip_image006.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="188" src="images/brvo_clip_image008.jpg"></p>
                                   <p><strong><u><h2>Treatment</h2></u></strong></p>
                                   <ol>
                                     <li><span dir="ltr"><strong>Medical treatment</strong> of  branch retinal vein occlusion (BRVO) is not effective. In the past, anticoagulants,  fibrinolytic agents, clofibrate capsules (Atromid-S), and carbogen inhalation  have been used but without success.</span></li>
                                     <li><span dir="ltr"><strong>Intravitreal injection of  Bevacizumab- </strong>Bevacizumab is a humanized recombinant monoclonal IgG antibody  that binds and inhibits all VEGF isoforms. Several small retrospective and  uncontrolled case series suggest that intravitreal bevacizumab at doses up to  2.5 mg are effective in improving visual acuity and reducing central macula  thickness in eyes with macular edema secondary to BRVO. These results are often  seen within 1 month of injection. However, most of the eyes will require  additional injections to maintain the effects of bevacizumab.</span></li>
                                     <li><span dir="ltr"><strong>Intravitreal injection of  Ranibizumab</strong>- A multicenter, prospective, phase III trial comparing intravitreal  ranibizumab and sham injections demonstrated the value of VEGF inhibition in  eyes with macular edema secondary to BRVO. In this study, eyes were randomized  to monthly sham injections, 0.3 mg of ranibizumab and 0.5 mg of ranibizumab,  for the first 6 months. Eyes were eligible for rescue laser at month 3 if the  hemorrhages had sufficiently cleared to allow safe treatment and if the visual  acuity remained at 20/40 or less and the central macular thickness was 250 µm  or less.</span></li>
                                     <li><span dir="ltr"><strong>Intravitreal injection  of&nbsp; Triamcinolone </strong>- Intravitreal  injection of triamcinolone has been used to treat macular edema of different  etiologies because of its potent antipermeability and anti-inflammatory  properties. A few cases of macular edema secondary to BRVO treated with an  intravitreal triamcinolone injection have been reported. The exact dose remains  unclear. Doses from 4 mg to 25 mg have been reported to be effective. </span></li>
                                     <li><span dir="ltr"><strong>Macular grid laser  photocoagulation- </strong>Macular grid laser photocoagulation remains the criterion  standard treatment of eyes with perfused macular edema secondary to BRVO</span></li>
                                     <li><span dir="ltr"><strong>Vitrectomy &amp;  arteriovenous decompression </strong>- Several surgeons have reported resolution of  macular edema secondary to BRVO after vitrectomy with or without peeling of the  internal limiting membrane. </span></li>
                                      <ul style="list-style: circle;padding-left: 20px;">
                                        <li><span dir="ltr">Vitrectomy and posterior hyaloid  separation improved the visual acuity in eyes with macular edema secondary to  BRVO. </span></li>
                                     </ul>
                                    </ol>
                                  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="156" src="images/brvo_clip_image010.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="156" src="images/brvo_clip_image012.jpg"></p></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">


                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><h2>CENTRAL RETINAL VEIN OCCLUSION (CRVO)</h2></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                 <p>The  actual mechanisms producing the clinical picture of central retinal vein  occlusion may be roughly divided into those conditions that produce a physical  blockage at the level of the lamina cribrosa, and those conditions in which  hemodynamic factors result in an obstruction to the flow of blood. These  mechanisms probably coexist in many patients with Central Vein Occlusion.</p>
                                     <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="156" src="images/crvo_clip_image002.jpg"></p>
                                   <p><strong><u><h4>Etiology</h4></u></strong></p>
                                   <ul>
                                     <li><span dir="ltr">An increased risk of central retinal vein occlusion was found in  patients with systemic hypertension, diabetes mellitus, and open-angle  glaucoma; the risk of central vein occlusion was decreased for patients with  increasing levels of physical activity and increasing levels of alcohol  consumption. </span></li>
                                     <li><span dir="ltr">For women, the risk decreased with the use of postmenopausal estrogen  and increased with a higher erythrocyte sedimentation rate. </span></li>
                                    </ul>
                                   <p><strong><u><h4>Two types of CRVO</h4></u></strong></p>
                                   <ul>
                                     <li><span dir="ltr"><strong>Ischemic CRVO</strong> - Patients with an ischemic pattern are usually aware of a sudden, painless decrease in  visual acuity. Vision ranges from 20/400 to hand movements. </span></li>
                                      <ul>
                                        <li><span dir="ltr">The onset, however, is generally not as rapid or the visual loss as  extensive as in central retinal artery occlusion. </span></li>
                                        <li><span dir="ltr">Exceptional cases have been noted in which patients with an acute onset  had reasonably good vision and yet demonstrated a picture of ischemic central  retinal vein occlusion. </span></li>
                                     </ul>
                                     <li><span dir="ltr"><strong>Non Ischemic CRVO</strong> - Nonischemic central retinal vein  occlusion is a much milder and more variable disease in appearance, symptoms,  and course compared with ischemic central retinal vein occlusion</span></li>
                                    </ul>
                                   <p><strong><u><h4>Ophthalmic Features </h4></u></strong></p>
                                     <p><strong>Confluent  hemorrhages </strong>are the  most prominent ophthalmoscopic feature of an acute ischemic central retinal  vein occlusion These hemorrhages occur in a wide variety of shapes and sizes;  they are usually concentrated in the posterior pole, but may be seen throughout  the retina. Many hemorrhages are flame shaped, reflecting the orientation of  the nerve fibers. Dot and punctate hemorrhages are interspersed and indicate  involvement of the deeper retinal layers. Bleeding may be extensive, erupting  through the internal limiting membrane to form a preretinal hemorrhage or  extending into the vitreous. Small dot hemorrhages may be seen either isolated  or clustered around small venules. The entire venous tree is tortuous,  engorged, dilated, and dark. The retina is edematous, particularly in the  posterior pole; some of this edema may obscure portions of the retinal vessels. Cotton-wool patches (soft exudates) are often present.</p>
                                   <p>The <strong>disc  margin is blurred or obscured</strong>, and the precapillary arterioles appear  engorged. Splinter hemorrhages and edema are present on the disc surface and  extend into the surrounding retina. The physiologic cup is filled, and the  venous pulse is absent. The arterioles, often overlooked because of the other  more striking pathologic features, are frequently narrowed. Sometimes in  central retinal vein occlusion of acute onset, the fundus picture is less  dramatic, and all of the findings previously discussed may be present, but to a  lesser degree. Vision depends on extent of macular involvement</p>
                                   <p>&nbsp;</p>
                                   <p><img  height="192" src="images/crvo_clip_image003.jpg">&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/crvo_clip_image004.jpg">&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/crvo_clip_image005.jpg"></p>
                                   <p><strong>&nbsp;</strong></p>
                                   <p><strong><u><h4>Investigations</h4></u></strong></p>
                                   <ul>
                                     <li><span dir="ltr">All patients with central retinal vein occlusion should have a  comprehensive ophthalmic evaluation, including an appropriate evaluation for glaucoma.  In addition, they should be referred to their primary care physician for an  evaluation of cardiovascular risk factors, including hypertension and diabetes</span></li>
                                     <li><span dir="ltr">Standard investigations-</span>FBC, PV, ESR</li>
                                     <li><span dir="ltr">U+E, Creatinine</span></li>
                                     <li><span dir="ltr">LFT, Protein Electrophoreseis</span></li>
                                     <li><span dir="ltr">Random Glucose, Lipid</span></li>
                                     <li><span dir="ltr">Urine analysis</span></li>
                                     <li><span dir="ltr">Ophthalmic investigations – FFA, Colour Doppler </span></li>
                                    </ul>
                                   <p><strong><u><h4>FFA</h4></u></strong></p>
                                   <ul>
                                     <li><span dir="ltr">The intravenous fluorescein angiogram pattern of an ischemic central  retinal vein occlusion is usually characterized by a delayed filling time of  the venous tree of the retina, capillary and venous dilation, and extensive  leaking of fluorescein into the retina, particularly in the macular area and in  the area adjacent to the larger venous trunks and capillary nonperfusion may  not be noted at the time of initial occlusion, but are usually manifest shortly  thereafter. Late-phase photographs show patchy extravascular areas of  fluorescence and staining of the retinal veins. </span></li>
                                     <li><span dir="ltr">Microaneurysms may not be noted at the time of initial occlusion, but  are usually manifest shortly thereafter. </span></li>
                                     <li><span dir="ltr">Late-phase photographs show patchy extravascular areas of fluorescence  and staining of the retinal veins. Fluorescence in the macula indicates  capillary leakage and edema; this not only may account for much of the initial  visual loss in the acute phase, but may eventually result in permanent  structural changes. </span></li>
                                     <li><span dir="ltr">Fluorescence in the macula indicates capillary leakage and edema; this  not only may account for much of the initial visual loss in the acute phase,  but may eventually result in permanent structural changes</span></li>
                                     <li><span dir="ltr">The most serious complication of central retinal vein occlusion is  neovascularization. </span></li>
                                     <li><span dir="ltr">Neovascularization elsewhere (NVE) occurs less frequently than  neovascularization of the iris (NVI), and usually only in ischemic occlusions.</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="200" src="images/crvo_clip_image006.jpg"></p>
                                   <p><strong><u><h4>Treatment</h4></u></strong></p>
                                   <ol>
                                     <li><span dir="ltr">Medical management- No known  effective medical treatment is available for either the prevention of or the  treatment of central retinal vein occlusion (CRVO). Identifying and treating  any systemic medical problems to reduce further complications is important.  Because the exact pathogenesis of the CRVO is not known, various medical  modalities of treatment have been advocated by multiple authors with varying  success in preventing complications and in preserving vision.</span></li>
                                     <li><span dir="ltr"><strong>Intravitreal Bevacizumab- </strong>In  patients with macular edema, injection of bevacizumab (0.05 mL/1.25 mg) into  the vitreous cavity through pars plana has been shown to be effective not only  in resolving the edema but also in corresponding improvement in vision.</span></li>
                                      <ul>
                                        <li><span dir="ltr">Also, in patients with neovascular  glaucoma, a similar dose has shown significantly decreased angle  neovascularization and improved intraocular pressure control, both medically  and surgically.</span></li>
                                        <li><span dir="ltr">Even though the exact mechanism of  action of intravitreal injections of bevacizumab is not known, bevacizumab  probably reduces VEGF concentrations in the vitreous cavity. This leads to a  reduction in capillary permeability and macular edema. The main drawback of  these injections is post treatment recurrences of macular edema, requiring  repeat injections.</span></li>
                                        <li><span dir="ltr">Significant complications reported  due to the injection of bevacizumab include cataract, glaucoma, retinal  detachment, vitreous hemorrhage, and endophthalmitis</span></li>
                                     </ul>
                                     <li><span dir="ltr"><strong>Intravitreal injection of ranibizumab -</strong></span></li>
                                      <ul>
                                        <li><span dir="ltr">Vascular endothelial growth factor  (VEGF) expression is upregulated by hypoxia and was noted to be elevated in the  ocular fluids of patients with CRVO. One of the potent effects of VEGF is to  increase vascular permeability in the macula leading to visually significant  macular edema. </span></li>
                                        <li><span dir="ltr">Ranibizumab is a humanized,  affinity-matured VEGF antibody fragment that binds to and neutralizes all  isoforms of VEGF. Ranibizumab showed improved visual outcomes in patients with  neovascular age-related vascular degeneration due to its anti-VEGF activity.  The role of ranibizumab in the management of CRVO was reported in multiple  studies. Intraocular injections of 0.3 mg or 0.5 mg ranibizumab provided rapid  improvement in 6-month visual acuity and macular edema following CRVO, with low  rates of ocular and nonocular safety events.Long-term follow-up of these  patients is needed to know the persistence of these gains for more than 6  months.</span></li>
                                      </ul>
                                     <li><span dir="ltr">4)<strong> Dexamethasone intravitreal  implant</strong></span></li>
                                      <ul>
                                        <li><span dir="ltr">Dexamethasone is a potent,  water-soluble corticosteroid that can be delivered to the vitreous cavity by  the dexamethasone intravitreal implant (DEX implant; OZURDEX, Allergan; Irvine, Calif).  A DEX implant is composed of a biodegradable copolymer of lactic acid and  glycolic acid containing micronized dexamethasone. The drug-copolymer complex  gradually releases the total dose of dexamethasone over a series of months  after insertion into the eye through a small pars plana puncture using a  customized applicator system.</span></li>
                                      </ul>
                                   <p><img  height="136" src="images/crvo_clip_image008.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="138" src="images/crvo_clip_image010.jpg"></p>
                                   <li><span dir="ltr"><strong> Intravitreal injection of  triamcinolone</strong></span></li>
                                     <ul>
                                      <li><span dir="ltr">In patients with macular edema,  injection of triamcinolone (0.1 mL/4 mg) into the vitreous cavity through pars  plana has been shown to be effective not only in resolving the edema but also  in corresponding improvement in vision.</span></li>
                                       <li><span dir="ltr">Even though the exact mechanism of  action of intravitreal injections of corticosteroids is not known, the  triamcinolone crystals in the vitreous cavity probably reduce VEGF  concentrations in the vitreous cavity. This leads to a reduction in capillary  permeability and macular edema. The main drawback of an injection of  triamcinolone was post treatment recurrences of macular edema, requiring repeat  triamcinolone injections, typically every 3-6 months.</span></li>
                                       <li><span dir="ltr">In addition, significant complications  reported due to the injection of triamcinolone include cataract, glaucoma,  retinal detachment, vitreous hemorrhage, and endophthalmitis. </span></li>
                                    </ul>
                                     <li><span dir="ltr"><strong> Laser photocoagulation-</strong></span></li>
                                      <ul>
                                        <li><span dir="ltr">Laser photocoagulation is the  known treatment of choice in the treatment of various complications associated  with retinal vascular diseases (eg, diabetic retinopathy, branch retinal vein  occlusion). Panretinal photocoagulation (PRP) has been used in the treatment of  neovascular complications of CRVO for a long time. However, no definite  guidelines exist regarding exact indication and timing of PRP</span></li>
                                        <li><span dir="ltr">Argon green laser usually is used.  Laser parameters should be about 500-µm size, 0.1-0.2 second duration, and  power should be sufficient to give medium white burns. Laser spots are applied  around the posterior pole, extending anterior to equator. They should be about  1 burn apart and total 1200-2500 spots. </span></li>
                                        <li><span dir="ltr">If ocular media is hazy for laser  to be applied, cryoablation of the peripheral fundus is performed. About 16-32  transscleral cryo spots are applied from ora serrata posteriorly</span></li>
                                       </ul>
                                  </ol>
                                  </td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><strong><h2>CENTRAL  RETINAL ARTERY OCCLUSION (CRAO)</h2></strong></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;">
                                   <ul style="list-style: disc;padding-left:20px">
                                  <li><span dir="ltr"><strong>Epidemiology - </strong></span></li>
                                    <ul  style="list-style: circle;padding-left:20px">
                                      <li><span dir="ltr">Men &gt; Women</span></li>
                                      <li><span dir="ltr">Bilateral in 1 – 2 %</span></li>
                                      <li><span dir="ltr">&nbsp;May have other retinal vascular disease</span></li>
                                    </ul>
                                   <li><span dir="ltr"><strong>History- </strong></span></li>
                                    <ul  style="list-style: circle;padding-left:20px">
                                      <li><span dir="ltr">&nbsp;Occurs over period of seconds</span></li>
                                      <li><span dir="ltr">&nbsp;May have prior history of amaurosis fugax</span></li>
                                      <li><span dir="ltr">Painless</span></li>
                                      <li><span dir="ltr">Sudden loss of vision</span></li>
                                    </ul>
                                   </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="134" src="images/crao_clip_image002.jpg"></p>
                                   <p><strong><u><h4>Etiology</h4> </u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Systemic Hypertension 66%</span></li>
                                     <li><span dir="ltr">&nbsp;Diabetes mellitus 25%</span></li>
                                     <li><span dir="ltr">&nbsp;Cardiac valve disease 25%</span></li>
                                     <li><span dir="ltr">&nbsp;Carotid atherosclerosis 45%</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="143" src="images/crao_clip_image004.jpg"></p>
                                     <p><strong><u><h4>Ophthalmic Features</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Vision CF to Light Perception  (90%)</span></li>
                                     <li><span dir="ltr">Rarely No Light Perception</span></li>
                                     <li><span dir="ltr">Afferent pupillary defect</span></li>
                                     <li><span dir="ltr">Cherry Red Spot- Opacification of  ganglion cells around fovea, takes hours to develop and fades in 4-6 weeks. May  be “brown” in blacks.</span></li>
                                     <li><span dir="ltr">Both arteries &amp; veins gets  thinned.</span></li>
                                     <li><span dir="ltr">May develop rubeosis &amp;  glaucoma within 1 month</span></li>
                                     <li><span dir="ltr">Occurs in up to 15-20%</span></li>
                                     <li><span dir="ltr">&nbsp;Retinal neovascularization occurs but rarely</span></li>
                                     <li><span dir="ltr">&nbsp;Ipsilateral carotid obstruction</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="136" src="images/crao_clip_image006.jpg"></p>
                                   <p><strong><u><h4>Ophthalmic Features</h4></u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Fundus Fluorescein Angiography  (FFA)</span></li>
                                     <li><span dir="ltr">Electro Retinogram (ERG)</span></li>
                                     <li><span dir="ltr">Visual fields</span></li>
                                    </ul>
                                   <p><strong><u><h4>FFA</h4></u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Delayed A-V transit time</span></li>
                                     <li><span dir="ltr">Staining of optic nerve or point  of embolus</span></li>
                                     <li><span dir="ltr">&nbsp;&nbsp;&nbsp;&nbsp;Rare retinal vessel staining</span></li>
                                     <li><span dir="ltr">Normal choroidal pattern</span></li>
                                     <li><span dir="ltr">Complete lack of filling, rare in  only 2%</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="161" src="images/crao_clip_image008.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="254" src="images/crao_clip_image010.jpg"></p>
                                   <p><strong><u><h4>ERG</h4></u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">B-wave origin is inner retina,  thus CRAO gives, B wave reduction.</span></li>
                                     <li><span dir="ltr">&nbsp;A-wave is normal, since photoreceptors  perfused</span></li>
                                     <li><span dir="ltr">Compare with flat ERG seen in  ophthalmic artery occlusion</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="222" src="images/crao_clip_image012.jpg"></p>
                                   <p><strong><u><h4>Visual fields</h4></u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Often have a preserved temporal  island</span></li>
                                     <li><span dir="ltr">Spared islands corresponding to  cilioretinal sparring</span></li>
                                    </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/crao_clip_image014.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img  height="152" src="images/crao_clip_image016.jpg"></p>
                                   <p><strong><u><h4>Treatment</h4></u></strong></p>
                                   <ul  style="list-style: disc;padding-left:20px">
                                     <li><span dir="ltr">Digital massage to dislodge  embolus</span></li>
                                     <li><span dir="ltr">A/C Paracentesis</span></li>
                                     <li><span dir="ltr">&nbsp;IV acetazolamide</span></li>
                                     <li><span dir="ltr">&nbsp;Gas Inhalation: Carbogen, Oxygen</span></li>
                                     <li><span dir="ltr">&nbsp;Retrobulbar vasodilators</span></li>
                                     <li><span dir="ltr">&nbsp;Inject Fibrinolytic in supraorbital artery</span></li>
                                     <li><span dir="ltr">&nbsp;Emergent TPPV with/without PFCL</span></li>
                                     <li><span dir="ltr">&nbsp;YAG laser embolysis</span></li>
                                    </ul>
                                  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="149" src="images/crao_clip_image018.jpg"></p></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
        
                           <div class="about-left-section">

                              <table  border="0" align="center" cellpadding="0" cellspacing="0" class="Main_text">
                                 <tbody><tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Page_title"><strong><h2>CENTRAL SEROUS RETINOPATHY (CSR)</h2></strong></td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td  align="left" valign="top">&nbsp;</td>
                                 <td  align="left" valign="top" class="Main_text1" style="text-align:justify;"><p>&nbsp;</p>
                                   <ul style="list-style: disc;padding-left: 20px;"><li><span dir="ltr">A Chorioretinal disorder  characterized by an idiopathic localized serous detachment of the neural retina  in the macular region.</span></li>
                                   <li><span dir="ltr">Usually unilateral</span></li>
                                   </ul>
                                   <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="170" src="images/csr_clip_image002.jpg"></p>
                                   <p><strong><u><h4>Etiology</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Age: 20 – 50 years</span></li>
                                     <li><span dir="ltr">Gender: Male &gt; female</span></li>
                                     <li><span dir="ltr">Increased incidence in:</span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Emotional stress</span></li>
                                       <li><span dir="ltr">Type A personality</span></li>
                                       <li><span dir="ltr">Physical Strains</span></li>
                                       <li><span dir="ltr">People engaged in visually  demanding work</span></li>
                                       <li><span dir="ltr">Also found to be associated with  vasoconstrictive agents, endogenous hypercortisolism, Systemic corticosteroids,  SLE, Hypertension</span></li>
                                      </ul>
                                    </ul>
                                   <p><strong><u><h4>Ophthalmic Features</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr"><strong>Presentation: </strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Unilateral blurred vision with a  relative scotoma in the central visual field</span></li>
                                       <li><span dir="ltr">Unilateral metamorphopsia and/or  micropsia</span></li>
                                       <li><span dir="ltr">Patients with extrafoveal involvement  may be asymptomatic</span></li>
                                      </ul>
                                     <li><span dir="ltr"><strong>Visual acuity:</strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">V/A ranges from 6/5 to 6/60,  usually 6/9 – 6/12</span></li>
                                       <li><span dir="ltr">Acquired hyperopia</span></li>
                                       <li><span dir="ltr">Disparity between retinoscopy and  refraction</span></li>
                                      </ul>
                                   <p><img  height="144" src="images/csr_clip_image004.jpg"></p>
                                     <li><span dir="ltr"><strong>Fundus:</strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">A round to oval sensory retinal  detachment is present at the posterior pole</span></li>
                                       <li><span dir="ltr">SRF: clear or turbid ±  Precipitates in the posterior surface of the sensory detachment</span></li>
                                       <li><span dir="ltr">In some small PED within the  serous detachment may be evident</span></li>
                                      </ul>
                                     <li><span dir="ltr"><strong>Other features:</strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Impaired Dark adaptation</span></li>
                                       <li><span dir="ltr">Colour desaturation</span></li>
                                       <li><span dir="ltr">Increased retinal recovery time to  bright light</span></li>
                                       <li><span dir="ltr">Patients may present as bullous  inferior peripheral retinal detachment (non-rhegmatogenous), with a tract of  atrophic RPE from macular region (seen best with FFA)</span></li>
                                      </ul>
                                    </ul>
                                   <p><strong><u><h4>Investigations</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr">Fundus Fluorescein Angiography  (FFA)</span></li>
                                     <li><span dir="ltr">Slit Lamp Biomicroscopy</span></li>
                                     <li><span dir="ltr">Optical Coherence Tomography (  OCT)</span></li>
                                    </ul>
                                   <p><strong><u><h4>FFA</h4></u></strong></p>
                                   <ul style="list-style: disc;padding-left: 20px;">
                                     <li><span dir="ltr"><strong>Characteristic features:</strong></span></li>
                                     <ul style="list-style: circle;padding-left: 20px;">
                                       <li><span dir="ltr">Smoke-stack appearance:</span></li>
                                       <ul style="list-style: disc;padding-left: 20px;">
                                         <li><span dir="ltr">Small hyperfluorescent spot in the  early phase due to leakage of dye through the RPE</span></li>
                                         <li><span dir="ltr">Fluorescein passes into the  subretinal space and ascends vertically until the upper border, like a  smoke-stack, in the late venous phase</span></li>
                                         <li><span dir="ltr">The dye then spreads laterally,  taking on a “mushroom” or “umbrella” configuration until entire area of  detachment is filled</span></li>
                                        </ul>
                                       <li><span dir="ltr">Ink-blot appearance: less common</span></li>
                                       <ul style="list-style: disc;padding-left: 20px;">
                                         <li><span dir="ltr">Hyperfluorescent spot in early  phase , which enlarges centrifugally until the entire detachment is filled with  dye</span></li>
                                        </ul>
                                      </ul>
                                    </ul>
                                   <p><img  height="192" src="images/csr_clip_image006.jpg">&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/csr_clip_image008.jpg">&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/csr_clip_image010.jpg"></p>
                                     <p align="center"><strong>Smoke stack appearance</strong></p>
                                   <p></p>
                                     <p>&nbsp;</p>
                                     <p><img  height="192" src="images/csr_clip_image012.jpg">&nbsp;&nbsp;&nbsp;&nbsp; <img  height="192" src="images/csr_clip_image014.jpg" alt="Acquired 3c">&nbsp;&nbsp;&nbsp;&nbsp;<img  height="192" src="images/csr_clip_image016.jpg"></p>
                                     <p align="center"><strong>Ink blot appearance</strong></p>
                                     <p></p>
                                     <p><strong><u><h4>Slit Lamp Biomicroscopy</h4></u></strong></p>
                                     <ul>
                                       <ul style="list-style: circle;padding-left: 20px;">
                                         <li><span dir="ltr">Transparent blister in the  posterior pole between neural retina and RPE</span></li>
                                         <ul style="list-style: circle;padding-left: 20px;">
                                           <li><span dir="ltr">Beam splitting as the light  traverses the serous space</span></li>
                                           <li><span dir="ltr">Increased distance between the  retinal vessels and their shadows</span></li>
                                           <li><span dir="ltr">Absent foveal reflex</span></li>
                                           <li><span dir="ltr">Small dot like deposits in the  posterior of retina which is believed to be the precipitates of plasma proteins  including fibrin</span></li>
                                         </ul>
                                       </ul>
                                     </ul>
                                     <p><strong><u><h4>OCT</h4></u></strong><br>
                                       Can be used to quantify the amount and extent of  subretinal fluid<br>
                         &nbsp;&nbsp;&nbsp;&nbsp;<img  height="150" src="images/csr_clip_image018.jpg">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<img  height="150" src="images/csr_clip_image019.jpg"></p>
                                     <p>&nbsp;&nbsp;&nbsp;&nbsp;<img  height="178" src="images/csr_clip_image021.jpg"></p>
                                     <p><strong><u><h4>Treatment</h4></u></strong></p>
                                     <ul style="list-style: disc;padding-left: 20px;">
                                       <li><span dir="ltr"><strong>Observation:</strong> 3-4 months in  most first episodes of unilateral CSCR</span></li>
                                       <li><span dir="ltr"><strong>Laser photocoagulation</strong></span></li>
                                       <li><span dir="ltr"><strong>Systemic beta blockers</strong>: may  have a beneficial role, but not well proven</span></li>
                                     </ul>          </td>
                                 <td  align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="left" valign="top">&nbsp;</td>
                               </tr>
                                 <tr>
                                 <td colspan="3" align="center">&nbsp;</td>
                               </tr>
                              </tbody></table>

                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">
                              <div class="pbmit-short-description">
                                 <h2>surgical</h2>
                              </div>
                              <div class="pbmit-short-description">
                                 <p>Lorem ipsum dolor sit amet consectetur, adipisicing elit. Vero dolore voluptas fugit cupiditate nihil aperiam quo corporis excepturi incidunt praesentium! Quaerat alias corrupti neque, nihil consequuntur quam dolorum numquam? Voluptates.</p>
                              </div>
                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">
                              <div class="pbmit-short-description">
                                 <h2>surgical</h2>
                              </div>
                              <div class="pbmit-short-description">
                                 <p>Lorem ipsum dolor sit amet consectetur, adipisicing elit. Vero dolore voluptas fugit cupiditate nihil aperiam quo corporis excepturi incidunt praesentium! Quaerat alias corrupti neque, nihil consequuntur quam dolorum numquam? Voluptates.</p>
                              </div>
                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">
                              <div class="pbmit-short-description">
                                 <h2>surgical</h2>
                              </div>
                              <div class="pbmit-short-description">
                                 <p>Lorem ipsum dolor sit amet consectetur, adipisicing elit. Vero dolore voluptas fugit cupiditate nihil aperiam quo corporis excepturi incidunt praesentium! Quaerat alias corrupti neque, nihil consequuntur quam dolorum numquam? Voluptates.</p>
                              </div>
                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">
                              <div class="pbmit-short-description">
                                 <h2>surgical</h2>
                              </div>
                              <div class="pbmit-short-description">
                                 <p>Lorem ipsum dolor sit amet consectetur, adipisicing elit. Vero dolore voluptas fugit cupiditate nihil aperiam quo corporis excepturi incidunt praesentium! Quaerat alias corrupti neque, nihil consequuntur quam dolorum numquam? Voluptates.</p>
                              </div>
                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">
                              <div class="pbmit-short-description">
                                 <h2>surgical</h2>
                              </div>
                              <div class="pbmit-short-description">
                                 <p>Lorem ipsum dolor sit amet consectetur, adipisicing elit. Vero dolore voluptas fugit cupiditate nihil aperiam quo corporis excepturi incidunt praesentium! Quaerat alias corrupti neque, nihil consequuntur quam dolorum numquam? Voluptates.</p>
                              </div>
                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">
                              <div class="pbmit-short-description">
                                 <h2>surgical</h2>
                              </div>
                              <div class="pbmit-short-description">
                                 <p>Lorem ipsum dolor sit amet consectetur, adipisicing elit. Vero dolore voluptas fugit cupiditate nihil aperiam quo corporis excepturi incidunt praesentium! Quaerat alias corrupti neque, nihil consequuntur quam dolorum numquam? Voluptates.</p>
                              </div>
                           </div>
                        </div>

                        <div class="tab-content">
                           <!-- Content for the Surgical Services tab goes here -->
                           <div class="about-left-section">
                              <div class="pbmit-short-description">
                                 <h2>surgical</h2>
                              </div>
                              <div class="pbmit-short-description">
                                 <p>Lorem ipsum dolor sit amet consectetur, adipisicing elit. Vero dolore voluptas fugit cupiditate nihil aperiam quo corporis excepturi incidunt praesentium! Quaerat alias corrupti neque, nihil consequuntur quam dolorum numquam? Voluptates.</p>
                              </div>
                           </div>
                        </div>


                     </div>
                  </div>
               </div>
            </div>
         </section>






       </div>
       <!-- Page Content End -->

       <!-- footer -->
       <footer class="footer site-footer">
          <div class="footer-wrap pbmit-footer-big-area">
             <div class="container">
                <div class="row align-items-center">
                   <div class="col-md-9">
                      <div class="d-md-flex align-items-center justify-content-between">
                         <div class="pbmit-footer-logo">
                            <img class="pbmit-main-logo" src="images/logo.jpg" alt="Cardioly Demo1">
                         </div>
                         <div class="d-md-flex">
                            <div class="pbmit-footer-boxes col-md-6">
                               <div class="pbmit-footer-contact-info">
                                  <div class="pbmit-footer-contact-info-inner d-flex align-items-center">
                                     <!-- <i class="pbmit-base-icon-location"></i> -->
                                     <i class="fa fa-map-marker" aria-hidden="true"></i>
                                     <div class="pbmit-footer-contact-info-wrap">
                                        <span class="pbmit-label">Our Clinic Address</span> 312, 313, Iscon Center,<br/>
                                        Shivranjani Cross Roads,<br/>
                                        Satellite, Ahmedabad - 15
                                     </div>
                                  </div>
                               </div>
                            </div>
                            <div class="pbmit-footer-boxes col-md-6">
                               <div class="pbmit-footer-contact-info">
                                  <div class="pbmit-footer-contact-info-inner d-flex align-items-center">
                                    <i class="fa fa-phone" aria-hidden="true"></i>
                                     <!-- <i class="pbmit-base-icon-phone"></i> -->
                                     <div class="pbmit-footer-contact-info-wrap">
                                        <span class="pbmit-label">Phone Number</span> +91 79 2692 5232,
                                        <br> 2692 5242
                                     </div>
                                  </div>
                               </div>
                            </div>
                         </div>
                      </div>
                   </div>
                   <div class="col-md-3 pbmit-footer-social-icon">
                      <ul class="pbmit-social-links">
                         <li class="pbmit-social-li pbmit-social-facebook">
                            <a href="#" target="_blank" class="d-flex align-items-center justify-content-center">
                               <span>
                                <i class="fa fa-facebook-f"></i>
                            </span>
                            </a>
                         </li>
                         <li class="pbmit-social-li pbmit-social-twitter">
                            <a href="#" target="_blank" class="d-flex align-items-center justify-content-center">
                               <span>
                                <i class="fa fa-twitter"></i>
                            </span>
                            </a>
                         </li>


                      </ul>
                   </div>
                </div>
             </div>
          </div>
          <div class="pbmit-footer-widget-area">
             <div class="container">
                <div class="row">
                   <div class="col-md-6 col-lg-3">
                      <div class="widget pbmit-float-menu">
                         <h3 class="widget-title">Information</h3>
                         <ul>
                            <li class="menu-item ">
                               <a href="#">About Us</a>
                            </li>
                            <li class="menu-item ">
                               <a href="#">Customer</a>
                            </li>
                            <!-- <li class="menu-item ">
                               <a href="#">Service</a>
                            </li> -->
                            <li class="menu-item ">
                               <a href="#">Collections</a>
                            </li>
                            <li class="menu-item ">
                               <a href="#">Best Seller</a>
                            </li>
                            <li class="menu-item ">
                               <a href="#">Careers</a>
                            </li>
                            <li class="menu-item ">
                               <a href="#">Privacy Policy</a>
                            </li>
                            <li class="menu-item ">
                               <a href="#">Change Location</a>
                            </li>
                            <li class="menu-item ">
                               <a href="#">Expert Tips</a>
                            </li>
                         </ul>
                      </div>
                   </div>
                   <div class="col-md-6 col-lg-3">
                      <div class="pbmit-two-widget">
                         <div class="widget">
                            <h3 class="widget-title">Latest News</h3>
                            <ul class="pbmit-rpw-list">
                               <li>
                                  <a href="blog-details.html">
                                     <span class="pbmit-rpw-img">
                                        <img src="images/blog/blog-01s.jpg" class="img-fluid" alt="">
                                     </span>
                                  </a>
                                  <span class="pbmit-rpw-content">
                                     <span class="pbmit-rpw-title"><a href="blog-details.html">Is Running Really Good for the Heart?</a></span>
                                     <span class="pbmit-rpw-date"><a href="blog-details.html">August 27, 2020</a></span>
                                  </span>
                               </li>
                               <li>
                                  <a href="blog-details.html">
                                     <span class="pbmit-rpw-img">
                                        <img src="images/blog/blog-02s.jpg" class="img-fluid" alt="">
                                     </span>
                                  </a>
                                  <span class="pbmit-rpw-content">
                                     <span class="pbmit-rpw-title">
                                        <a href="blog-details.html">Modeling data increase to endovascular therapy</a>
                                     </span>
                                     <span class="pbmit-rpw-date">
                                        <a href="blog-details.html">August 27, 2020</a>
                                     </span>
                                  </span>
                               </li>
                            </ul>
                         </div>
                      </div>
                   </div>
                   <div class="col-md-6 col-lg-3">
                      <div class="widget">
                         <h3 class="widget-title">Newsletter</h3>
                         <div>Sign up today for hints, tips and the latest product news
                            <div class="pbmit-footer-newsletter">
                               <input type="email" name="EMAIL" placeholder="Your email address" required="">	
                               <button type="submit" value="Sign up">Submit 
                                  <!-- <i class="pbmit-base-icon-paper-plane"></i> -->
                                  <!-- <i class="pbmit-base-icon-paper-plane"></i> -->
                                  <i class="fa fa-paper-plane"></i>
                               </button> 
                            </div>
                         </div>
                      </div>
                   </div>
                   <div class="col-md-6 col-lg-3">
                      <div class="widget">
                         <h3 class="widget-title">Opening Hours</h3>
                         <ul class="pbmit-timelist-list">
                            <li><span class="pbmit-timelist-li-title">Mon – Tue</span>
                               <span class="pbmit-timelist-li-value">10:00 – 18:00</span>
                            </li>
                            <li><span class="pbmit-timelist-li-title">Wed – Thur</span>
                               <span class="pbmit-timelist-li-value">10:00 – 17:00</span>
                            </li>
                            <li><span class="pbmit-timelist-li-title">Fri – Sat</span>
                               <span class="pbmit-timelist-li-value">10:00 – 12:30</span>
                            </li>
                            <li><span class="pbmit-timelist-li-title">Saturday</span>
                               <span class="pbmit-timelist-li-value">10:00 – 12:30</span>
                            </li>
                            <li><span class="pbmit-timelist-li-title">Sunday</span>
                               <span class="pbmit-timelist-li-value">Closed</span>
                            </li>
                         </ul>
                      </div>
                   </div>
                </div>
             </div>
          </div>
          <div class="pbmit-footer-section pbmit-bg-color-global">
             <div class="container">
                <div class="pbmit-footer-text-inner">   
                   <div class="pbmit-footer-copyright-box"> © 2012  Rising Retina Clinic
                      <!-- <a href="index.html">Cardioly Demo1</a>, All Rights Reserved. -->
                   </div>
                   <div class="pbmit-footer-copyright-box mt-sm-3">
                      <ul>
                         <li class="pbmit-footer-menu li">
                            <a href="faq.html">FAQ</a>
                         </li>
                         <li class="pbmit-footer-menu li">
                            <a href="about-us1.html">About Us 1</a>
                         </li>
                         <li class="pbmit-footer-menu li">
                            <a href="contact-us.html">Contact Us</a>
                         </li>
                      </ul>
                   </div>
                </div>
             </div>
          </div>	
       </footer>
       <!-- footer End -->
       
    </div>
    <!-- page wrapper End -->

    <!-- Search Box Start Here -->
    <div class="pbmit-search-overlay">
       <div class="pbmit-icon-close"></div>
       <div class="pbmit-search-outer"> 
          <form class="pbmit-site-searchform">
             <input type="search" class="form-control field searchform-s" name="s" placeholder="Type Word Then Press Enter">
             <button type="submit">
                <i class="pbmit-base-icon-search-1"></i>
                
            </button>
          </form>
       </div>
    </div>
 <!-- Search Box End Here -->

    <!-- JS
       ============================================ -->
    <!-- jQuery JS -->
    <script src="js/jquery.min.js"></script>
    <!-- Popper JS -->
    <script src="js/popper.min.js"></script>
    <!-- Bootstrap JS -->
    <script src="js/bootstrap.min.js"></script>
    <!-- jquery Waypoints JS -->
    <script src="js/jquery.waypoints.min.js"></script>
    <!-- jquery Appear JS -->
    <script src="js/jquery.appear.js"></script>
    <!-- Numinate JS -->
    <script src="js/numinate.min.js"></script>
    <!-- Slick JS -->
    <script src="js/swiper.min.js"></script>
    <!-- Magnific JS -->
    <script src="js/jquery.magnific-popup.min.js"></script>
    <!-- Circle Progress JS -->
    <script src="js/circle-progress.js"></script> 
    <!-- countdown JS -->
    <script src="js/jquery.countdown.min.js"></script> 
    <!-- AOS -->
    <script src="js/aos.js"></script>
    <!-- Scripts JS -->
    <script src="js/scripts.js"></script><a href="#" class="scroll-to-top">
        <!-- <i class="pbmit-base-icon-up-open-big"></i>
        <i class="pbmit-base-icon-up-open-big"></i> -->
        <i class="fa fa-angle-up"></i>
    </a>
    <!-- Revolution JS -->
    <script src="revolution/rslider.js"></script>
    <script src="revolution/rbtools.min.js"></script>
    <script src="revolution/rs6.min.js"></script>

    <script>
      // Get all the tab content elements
      var tabContents = $('.tab-content');
      
      // Get the tab container element
      var tabContainer = $('#tab-container');
      
      // Get all the tab links
      var tabLinks = tabContainer.find('a');
      
      // Loop through each tab link and add a click event listener
      tabLinks.on('click', function(e) {
         e.preventDefault();
         var tab = $(this).parent();
         var tabContentIndex = tab.index();
         tab.siblings().removeClass('post-active');
         tab.addClass('post-active');
         tabContents.each(function(index) {
            if (index === tabContentIndex) {
               $(this).addClass('active').show();
            } else {
               $(this).removeClass('active').hide();
            }
         });
      });
       </script>
 
</body></html>